3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
10
Stomach Neoplasms
8
Neoplasm Metastasis
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Nasopharyngeal Carcinoma
5
Leukemia, Myeloid, Acute
5
Esophageal Neoplasms
5
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Endometrial Neoplasms
3
Adenocarcinoma Of Esophagus
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mouth Neoplasms
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Carcinoma, Squamous Cell
2
Anatomic Stage II Breast Cancer AJCC v8
2
Advanced Solid Tumors
2
Unresectable Locally Recurrent Rectal Cancer
1
Thymoma
1
Interventions
pegaspargase
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Asparaginase
2
tislelizumab
1
sugemalimab
1
selinexor
1
pembrolizumab
1
fludarabine
1
Vorinostat
1
Transplantation
1
Tomography, X-Ray Computed
1
Sirolimus
1
Methylprednisolone
1
Methotrexate
1
Melphalan
1
IMC-001
1
Cyclosporine
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Drug Therapy
×
90 days
×
Clear all
No trials found.